Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

BACKGROUND: Heparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association between different dosages of low molecular weight heparin (LMWH) and mortality among COVID-19 hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Paolisso, Pasquale, Bergamaschi, Luca, D’Angelo, Emanuela Concetta, Donati, Francesco, Giannella, Maddalena, Tedeschi, Sara, Pascale, Renato, Bartoletti, Michele, Tesini, Giulia, Biffi, Mauro, Cosmi, Benilde, Pizzi, Carmine, Viale, Pierluigi, Galié, Nazzareno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424043/
https://www.ncbi.nlm.nih.gov/pubmed/32848743
http://dx.doi.org/10.3389/fphar.2020.01124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424043/
https://www.ncbi.nlm.nih.gov/pubmed/32848743
http://dx.doi.org/10.3389/fphar.2020.01124

Ejemplares similares